Navigation Links
LVAS in Medical News

Thoratec Schedules Second Quarter Conference Call, Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...

AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure

...sity of Michigan and Columbia University Medical Center. The DuraHeart lvas is part of a new, third-generation class of artificial mechanical support t... death due to end-stage left ventricular failure. “The DuraHeart lvas is an important technological advancement in the field of mechanical circul...

Thoratec Announces Appointment of Paul LaViolette to Board of Directors

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...

Thoratec Presentation at JMP Securities Conference to be Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...

Thoratec Schedules First Quarter Conference Call, Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System), with more than 13,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...

Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission

...erapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Te...

Thoratec Presentation at Raymond James Conference to Be Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...

Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;

... commercially approved cardiac assist devices including the HeartMate II(R) lvas (Left Ventricular Assist System), which received U.S. approval for bridge-t...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 12,000 devices implanted in patients suffering from heart fa...

Thoratec Reports 34 Percent Increase in 2008 Revenues

...highlighted by the successful U.S. commercial launch of our HeartMate II(R) lvas (Left Ventricular Assist System) for bridge-to-transplantation (BTT) and th...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas (Left Ventricular Assist System) with more than 12,000 devices implanted in...

Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni...
LVAS in Medical Technology

Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants

ANN ARBOR, Mich., April 28 /PRNewswire/ -- Terumo Heart, Inc. announced a presentation at the recent ISHLT meeting in Boston. The presentation entitled "Long Term Circulatory Support with the DuraHeart(TM) Mag-Lev Centrifugal LVAS for Advanced Heart Failure Patients Eligible for Transplantatio...

DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial

ANN ARBOR, Mich., March 3 /PRNewswire/ -- Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication. (Logo: ht...

Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results

ANN ARBOR, Mich., Sept. 17 /PRNewswire/ -- Terumo Heart, Inc. announced today that it had a successful European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland. (Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO ) ...

Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September

ANN ARBOR, Mich., Sept. 6 /PRNewswire/ -- Terumo Heart Inc. announced today that it is planning a European Launch Symposium at the European Association of Cardio-Thoracic Surgeons (EACTS) meeting in Geneva, Switzerland on September 17, 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/2006102...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

...ccessful ongoing global expansion of the DuraHeart lvas program, the distinction for the 100th implant cam...e a very good quality of life." The DuraHeart lvas is the first, third-generation rotary blood pump d...le minimizing device wear and tear. The DuraHeart lvas is currently being studied in the DuraHeart Pivota...

Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial

...n therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) divisio...

Discharge of First U.S. DuraHeart(TM) Patient

...ional Co-Principal Investigator for the U.S. pivotal trial of the DuraHeart lvas commented on the recent discharge. "We are extremely pleased with the perfo...nd mechanical failure. Significant advances have been made in the DuraHeart lvas to potentially overcome these problems. Dr. Nojiri explained: "We have a un...

First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial

... 2008, patient support averaged 223 days with cumulative support of 43 years. The longest ongoing patient support is over three years. The DuraHeart lvas Pivotal Trial is a multi-center, prospective, non- randomized study of 140 patients and will include up to 40 centers. The device is intended to provi...

Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial

...proval is the final step to initiate the DuraHeart lvas U.S. Pivotal Trial following the completion of sta...art, Inc., said, "With the IRB approval, DuraHeart lvas will be the first third-generation centrifugal pum...s team on the U.S. Pivotal Trial." The DuraHeart lvas Pivotal Trial is a multi-center, prospective, non-...

Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation

... PMA (PreMarket Approval) application, allowing the use of its HeartMate II lvas (Left Ventricular Assist System) as a bridge-to-transplantation (BTT) in pa...lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 11,000 devices implanted in patients suffering from heart fa...
LVAS in Medical Products

VentrAssist LVAS

Description: VentrAssist is a new third generation cardiac assist system primarily designed as a permanent alternative to heart transplants for patients suffering heart failure. It is a blood pump that connects to the left ventricle of the diseased heart to help the ailing hearts pumping function and assi...
Company:Ventracor Inc.

Novacor LVAS

Description: WorldHeart's Novacor LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. Novacor LVAS has been implanted in more than 1,500 patients, and is the first mechanical circulatory support device to support a single pati...
Company:World Heart Corporation

HeartMate LVAS

Description: There are two versions of the HeartMate Left Ventricular Assist System (LVAS): the Vented Electric (XVE) LVAD, which is powered by wearable batteries that allow the patient to be mobile, and the Implantable Pneumatic (IP), which is powered by an external Drive Console. Both devices are fully implan...
Company:Thoratec

HeartMate II

Description:... to restore hemodynamic function and improve patient outcomes and quality of life. Through the rotary action of a single-moving part, the HeartMate II lvas can achieve long-term full circulatory support by pumping blood from the heart to the body at up to 10 liters per minute....
Company:Thoratec

LionHeart Left Ventricular Assist System (LVAS)

Description:...s with progressive, irreversible, end-stage (Class IV) congestive heart failure, for which heart transplantation is not an option. The Arrow LionHeart lvas is not intended as a bridge to transplant or as a bridge to recovery of ventricular function. It is a therapeutic option for patients who are ineligib...
Company:Arrow International, Inc.
LVAS in Biological Technology

Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)

... of Destination Therapy (DT) for the HeartMate II lvas (left ventricular assist system). The HeartMate II...anced-stage heart failure patients. An implantable lvas powered by a rotary pumping mechanism, the HeartMa...c(R) VAD (Ventricular Assist Device) and HeartMate lvas with more than 13,000 devices implanted in patient...

Thoratec Presentation at J.P. Morgan Conference to be Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni...

Thoratec Reports 44 Percent Increase in Third Quarter Revenues

...ancial performance was driven by the continued adoption of the HeartMate II lvas (Left Ventricular Assist System) for bridge-to-transplantation, which helpe...lure. The company's product lines include the Thoratec(R) VAD and HeartMate lvas with nearly 12,000 devices implanted in patients suffering from heart failu...

Thoratec Schedules Third Quarter 2008 Conference Call, Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Techni...

Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History

...scular Division, where quarterly revenues grew 11 percent year-over-year. This growth primarily reflects the continued adoption of the HeartMate II(R) lvas (Left Ventricular Assist System) in both Europe and through our U.S. clinical program. In addition, fourth quarter revenues at our International Techn...

Thoratec Presentation at JP Morgan Conference to be Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...

Thoratec Announces Appointment of Steven H. Collis to Board of Directors

...eloping products to treat cardiovascular disease. The company's product line includes the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...

Thoratec Presentation at Bear Stearns Conference To Be Webcast

...herapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...

Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel

...n therapies to address advanced stage heart failure. The company's product lines include the Thoratec VAD(R) (Ventricular Assist Device) and HeartMate lvas (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Tec...
Other Tags
(Date:4/23/2014)... research, published in the journal Oncotarget , ... different appearances or their own DNA signatures within ... difficult to design effective, targeted treatment strategies. , ... EGFR mutation and either the KRAS or BRAF ... by the EGFR gene mutation have that specific ...
(Date:4/23/2014)... has been a rapidly evolving pursuit with many ... in the research road, scientists have found a ... with the disease. The report, which appears in ... have important implications for developing novel treatments. , ... that for years, research has suggested a link ...
(Date:4/22/2014)... device has been shown to reduce seizures in patients ... When coupled with an innovative electrode placement planning system ... complete elimination of seizures in nearly half of the ... , That,s good news for a large portion of ... epilepsy whose seizures can,t be controlled with medications and ...
(Date:4/22/2014)... at UT Southwestern Medical Center are making breakthroughs that ... A team of physician-scientists at UT Southwestern has ... with natural anti-depressant properties) works inside the brain. Simultaneously, ... depression in the form of a neuroprotective drug known ... in April,s issue of Molecular Psychiatry, is ...
(Date:4/22/2014)... for Molecular Pathology (AMP) released a report today ... on recommendations for a molecular diagnostics curriculum at ... The report was prepared by the Medical Laboratory ... Training and Education Committee. "Our goal was to ... laboratory scientists appropriately in order to manage the ...
Breaking Medicine News(10 mins):Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 2Health News:Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches 3Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2
(Date:4/23/2014)... ripping open a dinner roll, a fuel cell catalyst ... hydrogen molecule. Now researchers have captured a view of ... its hydrogen feast. The view confirms previous hypotheses and ... better for alternative energy uses. , This study is ... hydrogen halves end up in the structure of a ...
(Date:4/23/2014)... of a unique rhythmic sound, recorded for decades in ... Antarctic minke whale ( Balaenoptera bonaerensis ). First described ... thought it sounded like a duck, the bio-duck sound ... Ocean, but its source has remained a mystery, until ... researchers deployed acoustic tags on two Antarctic minke whales ...
(Date:4/23/2014)... Buenos Aires yesterday, Argentina joins the European Molecular ... The move strengthens the ties between the European ... Argentinian scientists access to EMBL,s world-class facilities and ... since its inception, fostering excellent life science research ... core of EMBL,s mission," says EMBL Director General ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Scientists identify source of mysterious sound in the Southern Ocean 2Scientists identify source of mysterious sound in the Southern Ocean 3
Other Contents